GCC signs five-year software licensing agreement with Accelrys

The investigators in the GCC Chemical Genomics (GCC-CG) program will have access to Accelrys software, which will be used to support multi-disciplinary collaborative research and training programs for the treatment and prevention of rare and undertreated cancers.

GCC-CG director and co-founder Peter Davies said with upwards of thirty projects a year, GCC need to work together efficiently and generate results quickly with minimal time and resources spent on internal software development.

The licensed software includes the enterprise-scalable Accelrys Enterprise Platform supporting multi-center, collaborative information sharing and scientific innovation across partnering research organizations.

The system also includes Accelrys Pipeline Pilot, the Cloud-based Accelrys HEOS drug discovery information management workspace, the Accelrys Discovery Studio modeling and simulation application and Accelrys Biological Registration software.

"The ability to create Pipeline Pilot Web applications that can be freely shared with other academic researchers inside or outside the Consortia provides a significant collaboration and innovation benefit," Davies said.